Eli Lilly CEO David Ricks called the Medicare GLP-1 program "market expansionary." (Photo by Spencer Platt/Getty Images) Sign-ups for Medicare’s GLP-1 coverage plan keep expanding, and Eli Lilly is ...
The label expansion builds on Inluriyo’s existing monotherapy indication, approved about a year ago. (Angus Liu/Fierce Pharma) Eli Lilly is sharpening its competitive edge in the crowded oral SERD ...
Lilly will make an undisclosed strategic investment in QurCan as well as an upfront payment. (Angus Liu/Fierce Pharma) Eli Lilly’s ongoing attempt to strengthen its genetic medicine offering has seen ...
Sept 14 (Reuters) - Eli Lilly (LLY.N), opens new tab on Monday said it has captured more than 30% of new patients in the U.S. market for oral obesity treatments, narrowing the early lead gained by ...
Lilly still boasts a robust pipeline of next-gen obesity candidates, led by retatrutide. (iStock / Getty Images Plus) Eli Lilly has put the kibosh on an early-stage obesity drug after the candidate ...
Lilly Wachowski accused J.K. Rowling of "funding anti-trans legislation all over the world," calling her actions "trans genocide." Wachowski also referred to Rowling and Elon Musk as "literal Nazis." ...
There are a little more than three months until the premiere of HBO Max’s Harry Potter series, which means there’s still time to stop people who want to engage with its nostalgic, drab Muggleslop ...
Lilly Wachowski has accused J.K. Rowling of "funding trans genocide." The American filmmaker made this argument against HBO's new Harry Potter TV show. The Matrix co-director has long advocated for ...
Eli Lilly & Co. has been laying the groundwork for a broader move into women’s health, assembling experts and hunting for new medicines across conditions including bone health and endometriosis, ...
Eli Lilly (LLY) earns a BUY rating with a $1,220 price target, backed by 47% revenue growth and four straight EPS beats. Novo Nordisk (NVO) trades at a forward P/E of 14 with just 2% revenue growth, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results